Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jgar.2015.10.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit.
PLoS One
May 2019
Laboratório de Pesquisa em Ciências da Saúde, Universidade Federal da Grande Dourados-UFGD, Dourados-Mato Grosso do Sul, Brazil.
The global spread of carbapenem-resistant Acinetobacter baumannii (A. baumannii) strains has restricted the therapeutic options available to treat infections due to this pathogen. Understanding the prevalence of such infections and the underlying genetic mechanisms of resistance may help in the implementation of adequate measures to control and prevent acquisition of nosocomial infections, especially in an intensive care unit setting.
View Article and Find Full Text PDFEmergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru.
Emerg Microbes Infect
July 2018
ISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Carbapenem-resistant Acinetobacter baumannii is the top-ranked pathogen in the World Health Organization priority list of antibiotic-resistant bacteria. It emerged as a global pathogen due to the successful expansion of a few epidemic lineages, or international clones (ICs), producing acquired class D carbapenemases (OXA-type). During the past decade, however, reports regarding IC-I isolates in Latin America are scarce and are non-existent for IC-II and IC-III isolates.
View Article and Find Full Text PDFOXA-23-producing ST25 Acinetobacter baumannii: First report in Bolivia.
J Glob Antimicrob Resist
March 2016
Department of Medical Biotechnologies, University of Siena, Santa Maria alle Scotte University Hospital, 53100 Siena, Italy. Electronic address: